Bioventus Inc.BVSEarnings & Financial Report
Nasdaq
NextMar 31, 2026
BVS Q3 2025 Key Financial Metrics
Revenue
$138.7M
Gross Profit
$94.2M
Operating Profit
$11.3M
Net Profit
$3.2M
Gross Margin
68.0%
Operating Margin
8.1%
Net Margin
2.3%
YoY Growth
-0.2%
EPS
$0.05
Financial Flow
Bioventus Inc. Q3 2025 Financial Summary
Bioventus Inc. reported revenue of $138.7M for Q3 2025, with a net profit of $3.2M (2.3% margin). Cost of goods sold was $44.4M, operating expenses totaled $83.0M.
Key Financial Metrics
| Total Revenue | $138.7M |
|---|---|
| Net Profit | $3.2M |
| Gross Margin | 68.0% |
| Operating Margin | 8.1% |
| Report Period | Q3 2025 |
Bioventus Inc. Annual Revenue by Year
Bioventus Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $573.3M).
| Year | Annual Revenue |
|---|---|
| 2024 | $573.3M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $135.4M | $129.5M | $151.2M | $139.0M | $153.6M | $123.9M | $147.7M | $138.7M |
| YoY Growth | 5.3% | N/A | 27.0% | 15.0% | 13.5% | -4.3% | -2.4% | -0.2% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $810.9M | $794.2M | $792.2M | $769.5M | $728.0M | $691.4M | $706.8M | $701.6M |
| Liabilities | $589.8M | $576.8M | $603.1M | $582.7M | $542.4M | $505.9M | $505.5M | $494.3M |
| Equity | $173.6M | $171.3M | $150.9M | $148.7M | $147.9M | $148.1M | $161.2M | $166.1M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $-6.0M | $15.2M | $10.3M | $19.3M | $-19.3M | $25.9M | $30.1M |